Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6996053 | 0.79 | SIGMAR1 (0.51) | AOC3TSHRCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL6024122 | 0.77 | GRIK1 (0.49) | CYP2D6CYP2C9CYP2C19KMT2ASIGMAR1 | |
| SCHEMBL114246 | 0.77 | CYP2D6 (0.46) | CYP2D6CYP2C9CYP2C19KMT2ALMNA | |
| SCHEMBL18948459 | 0.77 | CYP2D6 (0.46) | CYP2D6CYP2C9CYP2C19KMT2ALMNA | |
| SCHEMBL10472566 | 0.76 | CYP2D6 (0.49) | CYP2D6CYP2C9CYP2C19KMT2ALMNA | |
| SCHEMBL560468 | 0.76 | CYP2D6 (0.49) | CYP2D6CYP2C9CYP2C19KMT2ALMNA | |
| SCHEMBL2571201 | 0.76 | CYP2D6 (0.49) | CYP2D6CYP2C9CYP2C19KMT2ALMNA | |
| SCHEMBL13381443 | 0.74 | L3MBTL1 (0.48) | TSHRKMT2ASIGMAR1 | |
| SCHEMBL19539215 | 0.73 | CYP2D6 (0.46) | CYP2D6CYP2C9CYP2C19KMT2ALMNA | |
| SCHEMBL3712834 | 0.72 | SLC6A2 (0.56) | AOC3SIGMAR1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0973774-B1 | 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES | BAYER AG (DE) | 2003-01-22 | — | — | EP | disclosed |
| US-6174884-B1 | CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 2001-01-16 | — | — | US | disclosed |
| EP-0973774-A1 | 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES | BAYER AG (DE) | 2000-01-26 | — | — | EP | disclosed |
| WO-1998040384-A1 | 1,5-DIHYDRO-PYRAZOLO[3,4-D]-PYRIMIDINONE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-09-17 | — | — | WO | disclosed |